Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Ashkan Abbey, MD, Publishes Article Summarizing Highlights from American Academy of Ophthalmology Retina 2019 Subspecialty Day
Texas Retina Associates’ Ashkan Abbey, MD, recently published an article in the current issue of Retina Specialist that summarized the findings of five compelling clinical trial presentations from the American Academy of
read more
Ashkan Abbey, MD, Presents at the 52nd Scientific Program of The Retina Society
Our physicians are passionate about saving sight through innovation. This past weekend, Texas Retina Associates’ Ashkan Abbey, MD, spoke at the 52nd Scientific Program of The Retina Society in London. The Retina
read more
Ashkan Abbey, MD, Publishes Article on Key Retina Research Findings Presented at ARVO Meeting
Texas Retina Associates’ Ashkan Abbey, MD, serves on the editorial board of Retina Specialist, a medical journal focused on the latest advances in the diagnosis, medical management and surgical treatment of diseases
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more
Getting to Know Ashkan M. Abbey, MD
Board-certified retina specialist Ashkan M. Abbey, MD, joined Texas Retina Associates in 2015, and cares for patients in our Dallas Main and Rockwall offices. Originally from Tallahassee, Florida, Dr. Abbey speaks English, Farsi and
read more